Pharos Energy Valuation
Is PHARL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PHARL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PHARL (£0.24) is trading below our estimate of fair value (£0.64)
Significantly Below Fair Value: PHARL is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PHARL?
Key metric: As PHARL is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is PHARL's PS Ratio? | |
---|---|
PS Ratio | 0.9x |
Sales | US$137.60m |
Market Cap | US$119.41m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.7x |
Enterprise Value/EBITDA | 1x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does PHARL's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.9x | ||
KIST Kistos Holdings | 0.5x | 20.1% | UK£89.1m |
JSE Jadestone Energy | 0.4x | 2.8% | UK£128.7m |
CASP Caspian Sunrise | 2.5x | -11.2% | UK£76.7m |
ENQ EnQuest | 0.2x | -9.7% | UK£224.7m |
PHARL Pharos Energy | 0.9x | -8.0% | UK£95.3m |
Price-To-Sales vs Peers: PHARL is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (0.9x).
Price to Sales Ratio vs Industry
How does PHARL's PS Ratio compare vs other companies in the GB Oil and Gas Industry?
Price-To-Sales vs Industry: PHARL is good value based on its Price-To-Sales Ratio (0.9x) compared to the UK Oil and Gas industry average (1.4x).
Price to Sales Ratio vs Fair Ratio
What is PHARL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.9x |
Fair PS Ratio | 0.5x |
Price-To-Sales vs Fair Ratio: PHARL is expensive based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | UK£0.23 | UK£0.44 +89.0% | 33.7% | UK£0.60 | UK£0.24 | n/a | 3 |
Nov ’25 | UK£0.21 | UK£0.44 +106.6% | 33.7% | UK£0.60 | UK£0.24 | n/a | 3 |
Oct ’25 | UK£0.23 | UK£0.44 +92.3% | 33.7% | UK£0.60 | UK£0.24 | n/a | 3 |
Sep ’25 | UK£0.26 | UK£0.38 +49.4% | 34.0% | UK£0.50 | UK£0.20 | n/a | 3 |
Aug ’25 | n/a | UK£0.38 0% | 34.0% | UK£0.50 | UK£0.20 | n/a | 3 |
Jul ’25 | UK£0.24 | UK£0.38 +59.2% | 34.4% | UK£0.50 | UK£0.20 | n/a | 3 |
Jun ’25 | UK£0.24 | UK£0.38 +57.6% | 34.4% | UK£0.50 | UK£0.20 | n/a | 3 |
May ’25 | UK£0.23 | UK£0.38 +66.8% | 34.2% | UK£0.50 | UK£0.20 | n/a | 3 |
Apr ’25 | UK£0.21 | UK£0.38 +79.2% | 34.2% | UK£0.50 | UK£0.20 | n/a | 3 |
Mar ’25 | UK£0.20 | UK£0.39 +97.5% | 34.4% | UK£0.50 | UK£0.20 | n/a | 3 |
Feb ’25 | UK£0.21 | UK£0.40 +85.5% | 28.5% | UK£0.50 | UK£0.24 | n/a | 3 |
Jan ’25 | UK£0.23 | UK£0.43 +87.0% | 24.8% | UK£0.55 | UK£0.29 | n/a | 3 |
Dec ’24 | UK£0.21 | UK£0.44 +113.0% | 24.5% | UK£0.56 | UK£0.30 | n/a | 3 |
Nov ’24 | UK£0.22 | UK£0.44 +97.7% | 24.5% | UK£0.56 | UK£0.30 | UK£0.21 | 3 |
Oct ’24 | UK£0.23 | UK£0.38 +64.0% | 34.5% | UK£0.55 | UK£0.24 | UK£0.23 | 4 |
Sep ’24 | UK£0.23 | UK£0.38 +66.3% | 35.2% | UK£0.56 | UK£0.24 | UK£0.26 | 4 |
Aug ’24 | UK£0.24 | UK£0.37 +57.5% | 35.2% | UK£0.55 | UK£0.23 | n/a | 4 |
Jul ’24 | UK£0.22 | UK£0.38 +70.0% | 33.1% | UK£0.55 | UK£0.24 | UK£0.24 | 4 |
Jun ’24 | UK£0.23 | UK£0.38 +69.5% | 32.0% | UK£0.55 | UK£0.24 | UK£0.24 | 4 |
May ’24 | UK£0.23 | UK£0.38 +68.8% | 31.8% | UK£0.54 | UK£0.24 | UK£0.23 | 4 |
Apr ’24 | UK£0.23 | UK£0.39 +72.4% | 31.4% | UK£0.55 | UK£0.25 | UK£0.21 | 4 |
Mar ’24 | UK£0.26 | UK£0.39 +53.6% | 31.1% | UK£0.56 | UK£0.25 | UK£0.20 | 4 |
Feb ’24 | UK£0.23 | UK£0.38 +63.9% | 32.1% | UK£0.55 | UK£0.24 | UK£0.21 | 4 |
Jan ’24 | UK£0.23 | UK£0.48 +111.1% | 38.2% | UK£0.71 | UK£0.25 | UK£0.23 | 4 |
Dec ’23 | UK£0.25 | UK£0.48 +89.4% | 38.2% | UK£0.71 | UK£0.25 | UK£0.21 | 4 |
Nov ’23 | UK£0.26 | UK£0.48 +82.2% | 38.2% | UK£0.71 | UK£0.25 | UK£0.22 | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
TotalEnergies
€130.2b
A multi-energy company, produces and markets oil and biofuels, natural gas, green gases, renewables, and electricity in France, rest of Europe, North America, Africa, and internationally.
TTE
€59.70
7D
1.7%
1Y
-5.6%
Avance Gas Holding
NOK 8.1b
Engages in the transportation of liquefied petroleum gas (LPG) worldwide.
0QTX
NOK 104.60
7D
-3.3%
1Y
-40.6%
VAALCO Energy
US$561.3m
An independent energy company, engages in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids in Gabon, Egypt, Equatorial Guinea, and Canada.
EGY
US$4.63
7D
0%
1Y
28.5%